American Hospital Association December 19, 2025

The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models.

The first proposed rule would implement a new Medicare payment model called the Global Benchmark for Efficient Drug Pricing Model, also known as the GLOBE Model. The GLOBE Model would test an alternative calculation for manufacturer rebates under the Medicare Part B Inflation Rebate Program that uses a benchmark derived from international pricing information instead of the current domestic benchmark. The benchmark would be based on either manufacturer-reported international pricing information or available information to CMS for economically similar countries....

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Reengineering ACOs To Make Medicare Competitive
Major CMS‑Recognized Hospital Types
No Surprises disputes increasing even as arbiters catch up, CMS says
CMS proposes nearly flat Medicare Advantage payments for 2027: 6 notes
The Persistent Rising Tide of U.S. Health Care Spending

Share Article